Pedersini, Rebecca
 Distribuzione geografica
Continente #
NA - Nord America 634
EU - Europa 390
AS - Asia 142
OC - Oceania 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.171
Nazione #
US - Stati Uniti d'America 628
DE - Germania 112
IT - Italia 93
CN - Cina 66
UA - Ucraina 46
FI - Finlandia 41
HK - Hong Kong 34
CZ - Repubblica Ceca 23
GB - Regno Unito 22
SG - Singapore 21
RU - Federazione Russa 20
IE - Irlanda 13
ID - Indonesia 10
IN - India 9
CH - Svizzera 7
FR - Francia 6
CA - Canada 5
AU - Australia 2
RO - Romania 2
BE - Belgio 1
BY - Bielorussia 1
CR - Costa Rica 1
EU - Europa 1
FK - Isole Falkland (Malvinas) 1
HU - Ungheria 1
IM - Isola di Man 1
MU - Mauritius 1
NL - Olanda 1
PH - Filippine 1
TR - Turchia 1
Totale 1.171
Città #
Fairfield 104
Woodbridge 67
Chandler 43
Ashburn 41
New York 38
Seattle 38
Cambridge 36
Jacksonville 35
Hong Kong 34
Wilmington 33
Helsinki 32
Houston 32
Beijing 22
Boardman 21
Princeton 20
Ann Arbor 16
Brno 15
Brescia 13
Dublin 13
Munich 12
Singapore 11
Dalmine 10
Jakarta 10
Los Angeles 9
Milan 9
Nanjing 8
Romola 8
Shanghai 8
Olomouc 7
Dearborn 6
Mumbai 6
Nanchang 6
Nürnberg 6
Changsha 5
Des Moines 5
Dietikon 5
Jinan 5
London 5
Perugia 5
Naples 4
San Diego 4
Genoa 3
Jiaxing 3
Lappeenranta 3
Rome 3
Toronto 3
Bergamo 2
Canberra 2
Cornuda 2
Giussano 2
Lancaster 2
Leipzig 2
Melfi 2
Orange 2
Ottawa 2
Pianello del Lario 2
Poli 2
S. Pietro 2
Shenyang 2
Turin 2
Altoona 1
Belluno 1
Calcinato 1
Clifton 1
Delhi 1
Douglas 1
Espoo 1
Galati 1
Gunzenhausen 1
Hefei 1
Hyderabad 1
Kocaeli 1
Lanzhou 1
Ma'anshan 1
Magdeburg 1
Mariano Comense 1
Menen 1
Mogilëv 1
Nave 1
Ningbo 1
Pasig 1
Prague 1
San Francisco 1
San José 1
Tianjin 1
Washington 1
Wuxi 1
Zhengzhou 1
Totale 878
Nome #
Should Adjuvant Weekly Paclitaxel Be Considered Less Efficacious Than Anthracyclines Plus Cyclophosphamide for Lower Risk Patients With Early-Stage Breast Cancer? 134
Adjuvant bisphosphonates in patients with breast cancer: Does the potency matter? 124
Pathologic Complete Response As a Potential Surrogate for the Clinical Outcome in Patients With Breast Cancer After Neoadjuvant Therapy: A Meta-Regression of 29 Randomized Prospective Studies. 124
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 115
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 114
Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge. 106
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study 90
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 56
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 31
Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis 29
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients 29
Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study 28
Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors 28
Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study 26
Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapy 23
Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of who fracture risk assessment tool (frax) and bone mineral density in real-life clinical practice 23
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 20
Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy 20
Immune-related adverse events as potential surrogates of immune checkpoint inhibitors’ efficacy: a systematic review and meta-analysis of randomized studies 18
Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis 15
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 15
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients 14
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 11
Changes in body composition in early breast cancer patients treated with aromatase inhibitors 8
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter? 6
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies 4
Totale 1.211
Categoria #
all - tutte 8.099
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.099


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020191 0 0 0 26 16 25 24 25 24 32 5 14
2020/2021114 2 17 0 20 1 11 12 10 13 13 13 2
2021/202273 6 1 5 2 0 3 2 6 2 12 6 28
2022/2023133 11 2 3 9 12 34 0 12 17 11 17 5
2023/2024301 18 7 26 18 19 48 10 9 48 11 7 80
2024/202592 22 10 12 48 0 0 0 0 0 0 0 0
Totale 1.211